L1CAM and central nervous system cancer: Among potential therapeutic targets all the above mentioned factors have already been explored; bioinformatics demonstrate L1CAM gene is a miR503 (microRNA) target, miR503 overexpression reduces cell proliferation and invasion of glioma cells, suggesting it could be used as a L1CAM negative regulator/suppressor [140].